Description

6-(2-Bromo-Phenyl)-Imidazo[2,1-B]Thiazole-3-Carboxylic Acid is a high-purity, advanced pharmaceutical intermediate characterized by its fused heterocyclic structure containing bromine and carboxylic acid functional groups. This compound is critical for research and development in medicinal chemistry, serving as a versatile building block for synthesizing novel active pharmaceutical ingredients (APIs). It is primarily utilized by pharmaceutical R&D laboratories, agrochemical innovators, and specialty chemical manufacturers seeking to develop new therapeutic agents or functional materials.

Application

• Pharmaceutical Intermediate: A key precursor in the synthesis of novel drug candidates, particularly those targeting central nervous system (CNS) disorders, anti-infectives, or oncology.
• Medicinal Chemistry Research: Used as a core scaffold for structure-activity relationship (SAR) studies and library synthesis in drug discovery programs.
• Agrochemical Development: Serves as a building block for creating new fungicides or herbicides with specific modes of action.
• Material Science: Potential precursor for organic electronic materials or ligands in catalytic systems due to its conjugated heterocyclic system.
• Chemical Biology: Can be used to develop molecular probes or enzyme inhibitors for biochemical research.
• Custom Synthesis: Employed by contract research and manufacturing organizations (CROs/CMOs) for client-specific synthetic routes.

Basic Information

Product Name	6-(2-Bromo-Phenyl)-Imidazo[2,1-B]Thiazole-3-Carboxylic Acid
CAS No.	912770-08-2
Molecular Formula	C12H7BrN2O2S
Molecular Weight	323.17 g/mol
Synonyms	6-(2-Bromophenyl)imidazo[2,1-b][1,3]thiazole-3-carboxylic acid; 2-Bromo-6-imidazo[2,1-b]thiazole-3-carboxylic acid phenyl; Imidazo[2,1-b]thiazole-3-carboxylic acid, 6-(2-bromophenyl)-; 912770-08-2; 6-(o-Bromophenyl)imidazo[2,1-b]thiazole-3-carboxylic acid
EINECS	Contact for details

Quality Control

Our 6-(2-Bromo-Phenyl)-Imidazo[2,1-B]Thiazole-3-Carboxylic Acid is manufactured under strict quality management systems. Each batch undergoes comprehensive analytical testing, including HPLC for purity and identity confirmation via NMR and mass spectrometry, to ensure it meets the stringent requirements for pharmaceutical R&D. Certificates of Analysis (COA) detailing batch-specific results are provided and available upon request.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (typically 15-25°C). Keep away from incompatible materials. The container should be kept tightly sealed to protect from moisture.

Specification

Item	Specification
Appearance	Off-white to light yellow crystalline powder
Identification (HPLC)	Conforms to reference standard
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 97.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.